Skip to content

Ayahuasca: all studies

Page 135 of 167: studies 1,341 to 1,350 of 1,662, newest first. Back to the ayahuasca overview

Research

Vizionáriusok vs. szakértők

Kultúra és Közösség 2023 Orsolya Bajusz 1 citation

Tanulmányom a tanító (pszichoaktív) növények és a szakértők (pszichológusok) konfliktusának kibontásán keresztül a tudás, közvetítés különböző módozatainak ideológiai beágyazottságával, ezen keresztül világnézetek és különféle tudások konfliktusával foglalkozik, különösen a szubjektív, vizionárius tapasztalatra fókuszálva. A növények értelemszerűen nem ‘szakértőként’, tényeket és adatokat...

Endogenous Biosynthesis and Neural Correlates of N,N-dimethyltryptamine

Deep Blue (University of Michigan) 2023 Nicolas G. Glynos

N,N-dimethyltryptamine (DMT) belongs to a class of drugs known as serotonergic psychedelics, which produce profound shifts in consciousness by dramatically altering perception and causing hallucinatory phenomena. In humans, DMT has a rapid onset and the effects, which include feelings of dissociation from external reality, entering into an ‘otherworldly dimension’, and intense internal visual...

DOI: 10.7302/8314 (opens in new tab) Full text (opens in new tab) Endogeny Biosynthesis Biochemistry Enzyme

Towards an understanding of psychedelic-induced neuroplasticity.

Neuropsychopharmacology 2023 Abigail E. Calder, Gregor Hasler 303 citations

Classic psychedelics, such as LSD, psilocybin, and the DMT-containing beverage ayahuasca, show some potential to treat depression, anxiety, and addiction. Importantly, clinical improvements can last for months or years after treatment. It has been theorized that these long-term improvements arise because psychedelics rapidly and lastingly stimulate neuroplasticity. The focus of this review is...

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics

Therapeutic Advances in Psychopharmacology 2023 Ricarda Evens, Tomislav Majić, Timo Torsten Schmidt et al. 49 citations

Background: Classic serotonergic psychedelics have anecdotally been reported to show a characteristic pattern of subacute effects that persist after the acute effects of the substance have subsided. These transient effects, sometimes labeled as the ‘psychedelic afterglow’, have been suggested to be associated with enhanced effectiveness of psychotherapeutic interventions in the subacute period....

Efficacy and Safety of Psychedelics in Treating Anxiety Disorders

Ochsner Journal 2023 Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland et al. 25 citations

Background: Anxiety disorders are commonly diagnosed and cause substantial functional impairment. A mixture of pharmacologic and psychosocial treatments currently exists, but these treatments are not always tolerable and effective. For patients with anxiety resistant to standard therapy, psychedelics may be a promising alternative. This review assesses the therapeutic benefits and safety of...

Psychedelic Drug Legislative Reform and Legalization in the US

JAMA Psychiatry December 7, 2022 Joshua S. Siegel, James E. Daily, Demetrius Perry et al. 168 citations

Importance Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance for health care professionals, and planning for implementation and regulation. Objective To assess trends in psychedelics legislative reform and legalization in the US to provide guidance to health care...

Rumors of Psychedelics, Psychotropics and Related Derivatives in Vachellia and Senegalia in Contrast with Verified Records in Australian Acacia.

Plants December 2, 2022 Nicholas J Sadgrove 1 citation

There are almost 1000 species of Acacia sensu stricto in Australia, while the 44 species and 4 subspecies in southern Africa were taxonomically revised in the year 2011 to Senegalia and Vachellia. There are rumors of a chemical similarity between the Australian Acacia and their southern African sister genera. Chemical analysis has unequivocally demonstrated the presence of tryptamines (i.e.,...

DOI: 10.3390/plants11233356 (opens in new tab) Full text (opens in new tab) 5-methoxydimethyltryptamine Dimethyltryptamine DMT Phenethylamine Psychopharmacology +5

Substâncias psicotrópicas de origem natural: o que os usuários encontram na internet?

Vigilância Sanitária em Debate November 30, 2022 Juliana Pereira Lopes, Julino Assunção Rodrigues Soares Neto, Fúlvio Rieli Mendes

Introdução: A internet é um dos principais meios para o compartilhamento de informações, além de ser uma plataforma com recursos para o comércio on-line.Recentemente tem-se observado um aumento no interesse e consumo de substâncias psicotrópicas de origem natural, seja em um contexto religioso, cultural ou hedonístico.Objetivo: Avaliar se as informações sobre psicotrópicos de origem natural...

Recumbent Journeys Into Sound—Music, Imagery, and Altering States of Consciousness

November 10, 2022 Jörg Fachner 2 citations

The Bonny Method of Guided Imagery and Music (GIM) has evolved out of a pharmaco-supported psychotherapy setting in which the Altered State of Consciousness (ASC) has been evoked with strong psychedelic drugs. However, Helen Bonny observed that inducing an ASC with deep relaxation methods and a subsequent journey in a reclined or supine position elicited sufficient imagery for the therapy...

DOI: 10.4324/9780429330070-21 (opens in new tab) Guided imagery Mental image Consciousness Altered state +3

Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.

Pharmacology & Therapeutics November 1, 2022 Sanket B Raut, Padmaja A Marathe, Liza Van Eijk et al. 62 citations

Post-traumatic stress disorder (PTSD), characterized by abnormally persistent and distressing memories, is a chronic debilitating condition in need of new treatment options. Current treatment guidelines recommend psychotherapy as first line management with only two drugs, sertraline and paroxetine, approved by U.S. Food and Drug Administration (FDA) for treatment of PTSD. These drugs have...